Clinical trial Recruiting at 2 sites Interventional Ages 4 to 17

Using brain stimulation to help children with autism

Official title: Biologic Effects and Efficacy of Cerebellar tDCS in Children With Autism Spectrum Disorder

Run by University of Texas Southwestern Medical Center · NCT04446442 · Data updated 2026-11-12

This study is testing if a type of brain stimulation can help children and young adults with autism feel better by reducing symptoms like repetitive behaviors and hyperactivity.

Quick facts

Study typeInterventional
Ages4 Years to 17 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of Texas Southwestern Medical Center
Academic / other
Locations2 sites (Dallas, Texas and 1 other locations)
StatusRecruiting
StartedJune 4, 2019
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedJune 4, 2026
Trial IDNCT04446442 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 4-17 who have been diagnosed with autism spectrum disorder using the ADOS-2 assessment.

Probably not a fit

Patients with brain implants, epilepsy, or significant sensory impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research investigates the safety and effects of transcranial direct current stimulation (tDCS) applied to the cerebellum in children and young adults diagnosed with autism spectrum disorder (ASD). The study will involve 60 participants aged 4-17, who will undergo a randomized, double-blind, controlled design to assess changes in symptoms such as repetitive behaviors and hyperactivity. Participants will be screened for eligibility and will complete various tasks to establish baseline behavioral measurements before receiving the intervention. The study aims to gather data on the potential therapeutic effects of tDCS on ASD symptoms.

Why it matters

Potential benefit: If successful, this approach could provide a novel non-invasive treatment option for managing symptoms of autism spectrum disorder in children.

How similar studies have gone: While the use of tDCS is a relatively novel approach in this context, preliminary studies have shown promise in similar applications for neurological conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 4-17 years old
* Diagnosed with ASD and ADOS-2
* IQ Score no less than 70 (1.5 Standard Deviations below the mean)
* Language Level (Speech consists of, at minimum, flexible, spontaneous, simple, sentences)

Exclusion Criteria:

* Brain implants, metal implants, pacemakers, or biomedical devices
* Diagnosis of epilepsy
* Hearing or visual impairments
* History of brain injury
* Known brain abnormalities not associated with ASD

Where it's running

  • Children's Medical Center
    Dallas, Texas, United States
    Recruiting
  • University of Texas Southwestern
    Dallas, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.